[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Kaiu |
| 2. | Perekonnanimi | Prikk |
| 3. | Töökoht | Tervise Arengu Instituut |
| 4. | Ametikoht | teadur |
| 5. | Sünniaeg | 10.01.1966 (päev.kuu.aasta) |
| 6. | Haridus | Tartu Ülikooli arstiteaduskond, 1990 Internatuur Tartu Ülikool, 1991 Residentuur Tartu Ülikooli Kopsukllinikus, 1991-1994 Doktorantuur Tartu Ülikoolis 1999-2000 Doktorantuur Helsingi Ülikoolis 1999-2003 |
| 7. | Teenistuskäik | Internatuur Tartu Ülikooli Kopsukliinik, 1990-1991 Residentuur Tartu ülikooli Kopsukliinik, 1991-1994 Kopsuarst Tartu Ülikooli Kopsukliinik, 1994-2000 Kopsuarst, Ida-Tallinna Keskhaigla 2001-2003 Teadur Kopsuhaiguste Uurimise Ühing, Tervise Arengu Instituut, alates 2001 Kopsuarst, SA Põhja- Eesti Regionaalhaigla, Sisekliinik, alates 2003 |
| 8. | Teaduskraad | meditsiiniteaduste doktor |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Helsingi Ülikool, Arstiteaduskond, Soome, 2003 |
| 10. | Tunnustused | |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
Kopsuarstide Seltsi liige |
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Proteolüütiliste ensüümide osalus koekahjustuse tekkes ja progresseerumisel krooniliste põletikuliste kopsuhaiguste korral. |
| 14. | Jooksvad grandid | Koekahjustuse regulatsioon kroonilise obstruktiivse kopsuhaiguse tekkes ja arengus (090823Bs99) |
| 15. | Teaduspublikatsioonid |
R. Sepper, K.Prikk. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res. 2004; 3(2):277-81. E. Pirila, M.Parikka, NS.Ramamurthy, P.Maisi, S. McClain, A. Kucine, T. Tervahartiala; K.Prikk, LM. Golub, T.Salo, T. Sorsa. Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats:effects on matrix metalloproteinase-2, membrane type I matrix metalloproteinase, and laminin-5 gamma2-chain. Wound Repair Regen 2002, 10:38-51 Henry MT, McMahon K, Mackarel AJ, Prikk K, Sorsa T, Maisi P, Sepper R, Fitzgerald MX, O'Connor CM. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J 2002 Nov;20 (5):1220-7. K.Prikk, P.Maisi, E.Pirila, MA.Reintam, T.Salo, T.Sorsa, R.Sepper "Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma" Lab Invest 2002 Nov;82 (11):1535-45 P. Maisi, K.Prikk, R. Sepper, E. Pirila, T.Salo, T.Sorsa. “Activated soluble form of membrane-type I matrix metalloproteinase (MMP-14) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis” APMIS 2002; 110: 771-782 K.Prikk, E. Pirilä, R.Sepper, P. Maisi, J. Walghren, T.Salo, T.Sorsa.”In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis” J Pathol 2001; 193: 232-238. K.Prikk, P.Maisi, R. Sepper, UH. Stenman, T. Salo, T. Sorsa. “Association of trypsin-2 with gelatinase B and collagenase-2 activation in human lung in vivo“ Ann Med 2001; 33:437-444. P.Maisi, T.Sorsa, SM. Raulo, K.Prikk, B.McGorum, EA Kelly. Increased matrix metalloproteinase (MMP)-9 in the airway after allergen . Am J Respir Crit Care Med 2001; 164: 1740 Sepper R, Prikk K, Tervahartiala T, Konttinen YT, Maisi P, Lopez-Otin C, Sorsa T. Collagense-2, and -3 are inhibited by doxycycline in the chronically inflamed lung in bronchiectasis. Ann N Y Acad Sci 1999; 878:683-6855. |
viimati muudetud: 25.10.2004
| Curriculum Vitae (CV) | ||
| 1. | First Name | Kaiu |
| 2. | Surname | Prikk |
| 3. | Institution | National Institute for Health Development |
| 4. | Position | researcher |
| 5. | Date of birth | 10.01.1966 (day.month.year) |
| 6. | Education | Tartu University Medical Faculty, in 1990 Licentiate of internal medicine, Tartu University, medical doctor's licence, in 1991 Tartu University Lung Clinic, special training on pulmonology, 1991-1994 Post-graduate student, Institute of Biomedicine, University of Helsinki, Finland, in 1996, Ph.D. student at the Tartu University from 1996-2000 Ph.D. student at the University of Helsinki from 1999-2003 Doctoral thesis and Doctor of Medical Science Degree, Medical Faculty, University of Helsinki, in 2003 (“Development and progression of tissue injury in chronic inflammatory airway diseases with special respect to matrix metalloproteinases |
| 7. | Research and professional experience |
Tartu University Lung Clinic, intership, 1990-1991 Tartu University Lung Clinic, special training on pulmonology, 1991-1994 Tartu University Lung Clinic, pulmonary physician from 1994-2000 Tallinn Central Hospital from 2001-2003 Researcher at the Unit for Lung Investigations, National Institute for Health Development from 2001, North-Estonia Regional Hospital, pulmonary physician since 2003 |
| 8. | Academic degree | The degree of Doctor of Medical Science |
| 9. | Dates and sites of earning the degrees |
University of Helsinki, Faculty of Medicine, 2003 |
| 10. | Honours/awards | |
| 11. | Research-administrative experience |
member of Estonian Society of Lung Physicians |
| 12. | Supervised dissertations | |
| 13. | Current research program | Development and progression of tissue injury in chronic inflammatory airway diseases with special respect to proteolytical enzymes |
| 14. | Current grant funding | Regulation of tissue injury in chronic obstructive pulmonary diseases (090823Bs99) |
| 15. | List of most important publications |
R. Sepper, K.Prikk. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res. 2004; 3(2):277-81. E. Pirila, M.Parikka, NS.Ramamurthy, P.Maisi, S. McClain, A. Kucine, T. Tervahartiala; K.Prikk, LM. Golub, T.Salo, T. Sorsa. Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats:effects on matrix metalloproteinase-2, membrane type I matrix metalloproteinase, and laminin-5 gamma2-chain. Wound Repair Regen 2002, 10:38-51 Henry MT, McMahon K, Mackarel AJ, Prikk K, Sorsa T, Maisi P, Sepper R, Fitzgerald MX, O'Connor CM. Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF. Eur Respir J 2002 Nov;20 (5):1220-7. K.Prikk, P.Maisi, E.Pirila, MA.Reintam, T.Salo, T.Sorsa, R.Sepper "Airway obstruction correlates with collagenase-2 (MMP-8) expression and activation in bronchial asthma" Lab Invest 2002 Nov;82 (11):1535-45 P. Maisi, K.Prikk, R. Sepper, E. Pirila, T.Salo, T.Sorsa. “Activated soluble form of membrane-type I matrix metalloproteinase (MMP-14) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis” APMIS 2002; 110: 771-782 K.Prikk, E. Pirilä, R.Sepper, P. Maisi, J. Walghren, T.Salo, T.Sorsa.”In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis” J Pathol 2001; 193: 232-238. K.Prikk, P.Maisi, R. Sepper, UH. Stenman, T. Salo, T. Sorsa. “Association of trypsin-2 with gelatinase B and collagenase-2 activation in human lung in vivo“ Ann Med 2001; 33:437-444. P.Maisi, T.Sorsa, SM. Raulo, K.Prikk, B.McGorum, EA Kelly. Increased matrix metalloproteinase (MMP)-9 in the airway after allergen . Am J Respir Crit Care Med 2001; 164: 1740 Sepper R, Prikk K, Tervahartiala T, Konttinen YT, Maisi P, Lopez-Otin C, Sorsa T. Collagense-2, and -3 are inhibited by doxycycline in the chronically inflamed lung in bronchiectasis. Ann N Y Acad Sci 1999; 878:683-6855. |
last updated: 25.10.2004
[ sulge aken ]